Merck's Branded Generics Will Play A Supplementary, Country-specific Role

MUMBAI - Merck is putting into play a branded generics business strategy that involves extracting value out of a large set of its off-patented drugs through an aggressive push into developing markets, where the "lifecycle value of its brands" is significantly higher as compared to developed markets